These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10894593)

  • 1. Nitric oxide may contribute to nocturnal hemodynamic changes in cirrhotic patients.
    Genesca J; Segura R; Gonzalez A; Catalan R; Marti R; Torregrosa M; Cereto F; Martinez M; Esteban R; Guardia J
    Am J Gastroenterol; 2000 Jun; 95(6):1539-44. PubMed ID: 10894593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis.
    Genesca J; Gonzalez A; Segura R; Catalan R; Marti R; Varela E; Cadelina G; Martinez M; Lopez-Talavera JC; Esteban R; Groszmann RJ; Guardia J
    Am J Gastroenterol; 1999 Jan; 94(1):169-77. PubMed ID: 9934750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia.
    Guarner C; Soriano G; Tomas A; Bulbena O; Novella MT; Balanzo J; Vilardell F; Mourelle M; Moncada S
    Hepatology; 1993 Nov; 18(5):1139-43. PubMed ID: 8225220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement.
    Albillos A; de la Hera A; González M; Moya JL; Calleja JL; Monserrat J; Ruiz-del-Arbol L; Alvarez-Mon M
    Hepatology; 2003 Jan; 37(1):208-17. PubMed ID: 12500206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic hypotension and diuresis by L-arginine in cirrhotic patients with ascites: role of nitric oxide.
    Tajiri K; Miyakawa H; Izumi N; Marumo F; Sato C
    Hepatology; 1995 Nov; 22(5):1430-5. PubMed ID: 7590659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal functional reserve and nitric oxide in patients with compensated liver cirrhosis.
    Woitas RP; Heller J; Stoffel-Wagner B; Spengler U; Sauerbruch T
    Hepatology; 1997 Oct; 26(4):858-64. PubMed ID: 9328305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High plasma concentrations of nitrite/nitrate in patients with hepatocellular carcinoma.
    Moriyama A; Masumoto A; Nanri H; Tabaru A; Unoki H; Imoto I; Ikeda M; Otsuki M
    Am J Gastroenterol; 1997 Sep; 92(9):1520-3. PubMed ID: 9317076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation.
    Arkenau HT; Stichtenoth DO; Frölich JC; Manns MP; Böker KH
    Z Gastroenterol; 2002 Nov; 40(11):907-13. PubMed ID: 12436367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular responsiveness after isotonic exercise in cirrhotic patients: study on sympathoadrenergic and renin-angiotensin systems.
    Iwao T; Toyonaga A; Ikegami M; Sumino M; Oho K; Sakaki M; Shigemori H; Nakayama M; Tanikawa K; Iwao J
    Am J Gastroenterol; 1994 Jul; 89(7):1043-6. PubMed ID: 8017363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic hemodynamics and serum nitrate levels in patients undergoing endoscopic variceal ligation.
    Yokoyama M; Shijo H; Ota K; Kubara K; Kokawa H; Kim T; Akiyoshi N; Okumura M; Inoue K
    Hepatology; 1996 Jul; 24(1):47-52. PubMed ID: 8707281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-arginine infusion decreases plasma total homocysteine concentrations through increased nitric oxide production and decreased oxidative status in Type II diabetic patients.
    Cassone Faldetta M; Laurenti O; Desideri G; Bravi MC; De Luca O; Marinucci MC; De Mattia G; Ferri C
    Diabetologia; 2002 Aug; 45(8):1120-7. PubMed ID: 12189442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma substance P levels in patients with liver cirrhosis: relationship to systemic and portal hemodynamics.
    Lee FY; Lin HC; Tsai YT; Chang FY; Lu RH; Hou MC; Li CP; Chu CJ; Wang SS; Lee SD
    Am J Gastroenterol; 1997 Nov; 92(11):2080-4. PubMed ID: 9362197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic nitric oxide production and renal function in nonazotemic human cirrhosis: a reappraisal.
    Sansoè G; Silvano S; Mengozzi G; Smedile A; Todros L; Baronio M; Bonardi L; Rizzetto M
    Am J Gastroenterol; 2002 Sep; 97(9):2383-90. PubMed ID: 12358261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in hemodynamics and nitric oxide/endothelin-1 during liver transplantation in patients with cirrhosis].
    Hei ZQ; Luo CF; Li SR; Ma WH; Luo GJ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Oct; 17(10):592-4. PubMed ID: 16259914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of interleukin-18 and nitrite+nitrate in renal cell carcinoma patients with different tumor stage and grade.
    Sözen S; Coskun U; Sancak B; Bukan N; Günel N; Tunc L; Bozkirli I
    Neoplasma; 2004; 51(1):25-9. PubMed ID: 15004655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
    Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
    Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
    Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nitric oxide in pathogenesis of cirrhotic portal hypertension in rats and its hemodynamic effects].
    Zhang J; Zhou H
    Zhonghua Wai Ke Za Zhi; 1998 May; 36(5):317-9. PubMed ID: 11825400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.
    La Villa G; Barletta G; Pantaleo P; Del Bene R; Vizzutti F; Vecchiarino S; Masini E; Perfetto F; Tarquini R; Gentilini P; Laffi G
    Hepatology; 2001 Jul; 34(1):19-27. PubMed ID: 11431729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.